Abstract
This study evaluated implant outcome in patients with Down syndrome (DSPs) and provides clinical guidelines to maximize treatment outcome. A total of 57 implants were placed in eight DSPs. During follow-up, implant survival was recorded and crestal bone level was evaluated when possible. After a mean follow-up time of 5 years, six patients with 45 implants were evaluated and an implant survival rate of 84.4% was recorded. A mean crestal bone loss of 1.7 mm (SD 0.9) was measured in three patients around 20 implants. Down syndrome is not a contraindication to dental implant placement, but multiple complicating factors yield reduced implant survival.
| Original language | English |
|---|---|
| Pages (from-to) | 361-368 |
| Journal | International Journal of Periodontics and Restorative Dentistry |
| Volume | 39 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2019 |
| Externally published | Yes |
Funding
This study was supported by a research grant providing material support by Biomet3i (Palm Beach, FL, USA), and Prof De Bruyn disclosed on behalf of Ghent University a research and education grant from Biomet3i during the period of patient inclusion. The authors reported no conflicts of interest related to this study.
| Funders | Funder number |
|---|---|
| Universiteit Gent |